BlackRock Inc. - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 29 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$847
-6.7%
6180.0%0.00%
Q2 2023$908
+73.3%
6180.0%0.00%
Q1 2023$524
-99.1%
618
-98.6%
0.00%
Q4 2022$61,224
-21.5%
44,689
-2.0%
0.00%
Q3 2022$78,000
+73.3%
45,614
+108.5%
0.00%
Q2 2022$45,00021,8760.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 555,555$1,150,0000.31%
Ikarian Capital, LLC 105,341$217,0000.04%
Sarissa Capital Management LP 185,183$383,0000.04%
FEDERATED HERMES, INC. 2,904,826$6,013,0000.02%
Virtu Financial LLC 10,205$21,0000.00%
VICTORY CAPITAL MANAGEMENT INC 221,506$459,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 11,583$24,0000.00%
VANGUARD GROUP INC 372,732$772,0000.00%
UBS Group AG 8,252$17,0000.00%
Community Bank, N.A. 690$1,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders